Digital Technology
Lauxera Capital Partners Acquires Galen Data
12/6/24
[PRESS RELEASE]
Paris (France), Houston (USA), San Francisco (USA) — November 25, 2024 — Lauxera Capital Partners announces the acquisition of Galen Data, a leading provider of secure, cloud-based connectivity solutions for medical devices. This transaction follows Lauxera’s 2022 acquisition of Matrix Requirements, a leading ALM and eQMS software solution for medical device R&D and Quality teams.
This strategic transaction brings together two industry leaders serving the same end-customers with highly complementary products.
“The Galen team has built an exceptional product providing medical device companies a cost-effective, compliant, and secure solution for medical device cloud connectivity. Innovation in Medtech is no longer only about better electronic, metal, and plastic designs. Galen empowers Medtech companies to improve care by leveraging the data generated by their medical devices. “We are excited to work hand in hand with management to strengthen the company’s global commercial engine,” said Samuel Levy, Founding Partner, Lauxera Capital Partners.
For Galen Data, this acquisition represents an exciting new chapter with expanded financial resources and a broader, global team.
“We’re incredibly excited to join forces with Lauxera Capital Partners and Matrix Requirements. Their strategic insights and global reach will allow us to accelerate growth into new markets, expand our services, and continue delivering cutting-edge solutions to the medical device industry. This partnership empowers us to take our business to the next level and better serve our clients while pushing forward the innovation that’s at the core of everything we do,” Chris DuPont, CEO, Galen Data.
"This acquisition is an important step towards our vision to provide turnkey vertically-integrated software solutions to address pain points faced by medical devices companies. I am thrilled to welcome Galen’s team.” added Laurent Grandidier, Executive Chairman of the Board.
Lauxera Capital Partners was advised by Goodwin Proctor on legal and tax matters.
About Lauxera Capital Partners
Founded in January 2020, Lauxera Capital Partners is an independent asset management company based in France (Paris) and in the United States (San Francisco). Lauxera is a healthcare specialist investor working to promote the growth of European Healthtech companies. Its first fund, Lauxera Growth I, gathered 262m€ of capital from investors and had invested in 12 fast-growing Healthtech businesses in France, the UK, Germany, Sweden, Denmark and the United States. Led by a team of life sciences entrepreneurs and professional healthcare investors with more than 50 years’ experience, Lauxera aims to support the international commercial expansion of Europe's most promising Healthtech innovations. Lauxera’s highly focused investment approach, its intimacy with the US healthcare ecosystem, its distinctive understanding of innovation trends across Europe and the operating and investment experience of its partners enables Lauxera to be a strong value-add partner for its investee companies.
About Galen Data
Galen Data provides a secure, cloud-based platform designed to connect medical devices to the cloud, allowing for real-time data collection, storage, and analysis. Galen’s platform is compliant with key medical device industry standards, including FDA, HIPAA, GDPR, and CE Marking, which helps medical device companies accelerate time-to-market while ensuring regulatory compliance. Galen Data’s solution simplifies the process of managing connected medical devices by offering a secure and scalable infrastructure tailored to the needs of healthcare technology providers. Galen Data is an ISO 13485:2016 certified company and is HITRUST r2 Certified on AWS.
Read More